Literature DB >> 9062778

Prevalence of antibodies against enterically transmitted viral hepatitis (HAV and HEV) among adolescents in an inland territory of central Italy.

G Ripabelli1, M L Sammarco, T Campo, C Montanaro, E D'Ascenzo, G M Grasso.   

Abstract

A study on the seroprevalence of HAV and HEV infections among adolescents in an inland territory of central Italy (Molise region) was carried out. The prevalence of antibodies was respectively 3.3% and 0.4%. The results indicated that (1) anti-HAV prevalence in children is low but HAV infection is always present, and (2) HEV infection could be endemic and not necessarily imported.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9062778     DOI: 10.1023/a:1007393511106

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  15 in total

1.  Baseline seroepidemiology of hepatitis A virus infection among children and teenagers in Italy.

Authors:  T Stroffolini; M Chiaramonte; E Franco; M Rapicetta; D De Mattia; I Mura; R Trivello; A Giammanco; G Rigo; B Scarpa
Journal:  Infection       Date:  1991 Mar-Apr       Impact factor: 3.553

2.  The changing epidemiology of hepatitis A in Italy.

Authors:  T Stroffolini; R D'Amelio; P M Matricardi; P Chionne; A Napoli; M Rapicetta; S Crateri; P Pasquini
Journal:  Ital J Gastroenterol       Date:  1993 Aug-Sep

3.  Decline in anti-HAV prevalence in the Milan area between 1958 and 1992.

Authors:  A R Zanetti; L Romanò; E Tanzi; A Andreassi; A Pozzi; A Panuccio; T Stroffolini
Journal:  Eur J Epidemiol       Date:  1994-10       Impact factor: 8.082

4.  Hepatitis E in The Netherlands: imported and endemic.

Authors:  H L Zaaijer; M Kok; P N Lelie; R J Timmerman; K Chau; H J van der Pal
Journal:  Lancet       Date:  1993-03-27       Impact factor: 79.321

5.  Hepatitis E infection in acute sporadic hepatitis in Spain.

Authors:  R Jardi; M Buti; F Rodriguez-Frias; R Esteban
Journal:  Lancet       Date:  1993-05-22       Impact factor: 79.321

6.  Changing patterns of hepatitis A virus infection in children in Palermo, Italy.

Authors:  T Stroffolini; L De Crescenzo; A Giammanco; V Intonazzo; G La Rosa; A Cascio; A Sarzana; A Chiarini; L Dardanoni
Journal:  Eur J Epidemiol       Date:  1990-03       Impact factor: 8.082

7.  Epidemiology of hepatitis A in Mediterranean countries.

Authors:  G Papaevangelou
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

Review 8.  Hepatitis E.

Authors:  M A Purdy; K Krawczynski
Journal:  Gastroenterol Clin North Am       Date:  1994-09       Impact factor: 3.806

9.  Prevalence of antibodies against hepatitis E virus among urban and rural populations in Venezuela.

Authors:  F H Pujol; M O Favorov; T Marcano; J A Esté; M Magris; F Liprandi; Y E Khudyakov; N S Khudyakova; H A Fields
Journal:  J Med Virol       Date:  1994-03       Impact factor: 2.327

10.  Decline in the exposure to hepatitis A and B infections in children in Naples, Italy.

Authors:  P D'Argenio; D Esposito; A Mele; G Ortolani; B Adamo; M Rapicetta; P Forte; A Pisani; L Soldo; B Sarrecchia
Journal:  Public Health       Date:  1989-09       Impact factor: 2.427

View more
  3 in total

1.  Hepatitis A incidence and hospital-based seroprevalence in Italy: a nation-wide study.

Authors:  Filippo Ansaldi; Bianca Bruzzone; Maria Cristina Rota; Antonino Bella; Marta Ciofi degli Atti; Paolo Durando; Roberto Gasparini; Giancarlo Icardi
Journal:  Eur J Epidemiol       Date:  2007-11-03       Impact factor: 8.082

2.  Age-specific seroepidemiology of hepatitis A, B, and E infections among children in Istanbul, Turkey.

Authors:  M Sidal; E Unüvar; F Oğuz; C Cihan; D Onel; S Badur
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

3.  Age-specific seroprevalence of hepatitis A infection among children visited in pediatric hospitals of Tehran, Iran.

Authors:  Ali Jafari Mehr; Mohammad Javad Ehsani Ardakani; Mehdi Hedayati; Saeed Shahraz; Elnaz Jafari Mehr; Mohammad Reza Zali
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.